
A young woman sits stunned in an oncologist’s office, unsure of where to look or how to react to the …

Since 2010, I have spent a great deal of time of writing about NICE, covering nearly all of all its …

England’s Cancer Drugs Fund (CDF) is very good at creating division: its lobbyists say that it increases access to new …

Not long ago I was asked to be involved in a project that filmed UK-based pharma journalists in order to …
The year 2013 brought a new series of challenges for pharma. As the dust settled following the bulk of major …

In the past pharma has been accused of being too male-orientated in both the laboratory and the boardroom. The idea …